Healthcare has settled back into its normal late summer routine, with relatively little in the way of new product introductions or other market-moving data. That's not to say that the space is entirely quiet, though, as business continues to go on.

Investopedia Broker Guides: Enhance your trading with the tools from today's top online brokers.

Novo Continues to Drive One of the Greatest Growth Stories in Healthcare
Very few healthcare stocks are as expensive as Novo Nordisk (NYSE:NVO), but few companies deserve that sort of premium either. There aren't too many companies with multiple billions of dollars in revenue that are growing more than 20%, but Novo is managing to do so largely on the strength of its diabetes franchise. Novo Nordisk stands tall alongside Lilly (NYSE:LLY) and Sanofi (NYSE:SNY) in the insulin space, while its Victoza remains a leading pharmaceutical option for Type 2 diabetes.

While the FDA approval timeline for a new insulin product has slipped a bit, and the company does face a potentially rejuvenated competitor now that Bristol-Myers (NYSE:BMY) and AstraZeneca (NYSE:AZN) have completed the deal for Amylin and its long-acting Bydureon (a direct competitor to Victoza).

Another Alzheimer's Drug Fails
Last week, Johnson & Johnson (NYSE:JNJ) and Pfizer (NYSE:PFE) announced that they were more or less pulling the plug on their drug bapineuzumab for Alzheimer's. Not only did the companies announce a second Phase 3 trial failure, but also the companies are no longer intending to develop IV bapi any further. While an earlier stage Phase 2 subcutaneous trial continues, there is no particular reason to believe that this drug has any prospects in the treatment of mild-to-moderate Alzheimer's.

This news also increases the pressure on Lilly with its own Alzheimer's drug solanezumab. Prior to Phase 3 data from J&J and Pfizer, most analysts had assigned a higher probability of success to bapineuzumab than solanezumab, but the latter drug is a larger component of Lilly's potential pipeline revenue. In other words, Lilly's odds are worse but its needs are greater.

SEE: Investing In The Healthcare Sector

New Developments
Investors saw the week of August 13th start off with news that Sun Pharmaceutical and Taro Pharmaceutical (NYSE:TARO) managed to find common ground on a deal. Sun already owned two-thirds of Taro, but the company had rejected a prior offer of $24.50. With the offer hiked 60% to nearly $40 a share, though, Taro found a deal it could accept and will become wholly owned by Sun.

Pfizer is moving ahead with its asset monetization plans, announcing the filing of registration documents for the IPO of Zoetis - its animal health business. While the IPO is only scheduled to raise about $100 million, it should allow Pfizer to pursue a gradual divestment strategy for a business with more than $4 billion in revenue. It's also worth noting that while animal health is a sizable market, most animal health businesses are locked up inside larger companies and Zoetis will be a rare pure play for investors.

SEE: What Is a Pure Play?

The Bottom Line
The performance of healthcare stocks (as measured by ETFs) has begun to falter a bit. The Health Care Select Sector SPDR (ARCA:XLV) is up 11.8% year-to-date, slipping below the the 12.2% return of the S&P 500. The iShares Dow Jones U.S. Pharmaceuticals ETF (ARCA:IHE) is up 14%, while the iShares Dow Jones U.S. Medical Devices ETF (ARCA:IHI) is up 10.7%. The SPDR Biotech ETF (ARCA:XBI) has risen almost 28% year-to-date.

At the time of writing, Stephen D. Simpson did not own shares in any of the companies mentioned in this article.

Related Articles
  1. Stock Analysis

    Allstate: How Being Boring Earns it Billions (ALL)

    A summary of what Allstate Insurance sells and whom it sells it to including recent mergers and acquisitions that have helped boost its bottom line.
  2. Options & Futures

    Cyclical Versus Non-Cyclical Stocks

    Investing during an economic downturn simply means changing your focus. Discover the benefits of defensive stocks.
  3. Investing Basics

    How to Deduct Your Stock Losses

    Held onto a stock for too long? Selling at a loss is never ideal, but it is possible to minimize the damage. Here's how.
  4. Financial Advisors

    Breaking Down Medicare Open Enrollment for Clients

    For financial advisors, open enrollment is an important opportunity to be of service to clients, especially when it comes to reviewing Medicare options.
  5. Retirement

    Top Signs You Aren’t Ready to Retire Yet

    Think you are prepared to retire? These warning signs may indicate otherwise.
  6. Economics

    Is Wall Street Living in Denial?

    Will remaining calm and staying long present significant risks to your investment health?
  7. Stock Analysis

    When Will Dick's Sporting Goods Bounce Back? (DKS)

    Is DKS a bargain here?
  8. Investing News

    How AT&T Evolved into a Mobile Phone Giant

    A third of Americans use an AT&T mobile phone. How did it evolve from a state-sponsored monopoly, though antitrust and a technological revolution?
  9. Stock Analysis

    Home Depot: Can its Shares Continue Climbing?

    Home Depot has outperformed the market by a wide margin in the last 12 months. Is this sustainable?
  10. Stock Analysis

    Yelp: Can it Regain its Losses in 2016? (YELP)

    Yelp investors have had reason to be happy recently. Will the good spirits last?
  1. Is dental insurance tax deductible?

    Dental insurance premiums may be tax deductible. To be deductible as a qualifying medical expense, the dental insurance must ... Read Full Answer >>
  2. Does a Flexible Spending Account (FSA) cover massages?

    Flexible Spending Accounts (FSAs) cover massages for certain medical treatments. These treatments must be approved and prescribed ... Read Full Answer >>
  3. Do flexible spending accounts (FSA) funds roll over?

    An individual can utilize an employer’s cafeteria plan of employee benefits to establish a flexible spending account (FSA). ... Read Full Answer >>
  4. Does CareCredit cover prescriptions?

    In the United States, the health care sector is one of the fastest growing and costliest industries. The demand placed on ... Read Full Answer >>
  5. What are catch-up contributions for Health Savings Accounts (HSAs)?

    The U.S. Internal Revenue Service (IRS) allows an eligible individual with a Health Savings Accounts (HSA) who turns 55 or ... Read Full Answer >>
  6. Who can make catch-up contributions to a Health Savings Account (HSA)?

    An eligible individual who is 55 years or older at the end of his tax year can make additional catch-up contributions to ... Read Full Answer >>

You May Also Like

Trading Center